Contact this trialFirst, we need to learn more about you.
Nucleoside Analog
ASTX727 + Venetoclax for Acute Myeloid Leukemia
Recruiting1 awardPhase 1 & 2
Jacksonville, Florida
This trial is testing a new combination therapy for AML in adults who are age 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy. The goal is to see if the therapy is safe and works well together.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.